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Recent reports have found that the posthatch chicken retina has the capacity for neuronal regeneration. The purpose of this
study was to test whether the types of cells destroyed by neurotoxic lesions influence the types of cells that are regenerated,
and whether exogenous growth factors stimulate neural regeneration in the chicken retina. N-methyl-D-aspartate (NMDA)
was used to destroy amacrine and bipolar cells; kainate was used to destroy bipolar, amacrine, and ganglion cells; colchicine
was used to selectively destroy ganglion cells. Following toxin-induced damage, bromo-deoxyuridine was used to label
proliferating cells. In some animals, growth factors were injected into the vitreous chamber of the eye. We found that the
proliferation of cells within the retina was stimulated by toxin-induced cell loss, and by insulin and FGF2. After either
kainate- or colchicine-induced retinal damage, some of the newly generated cells expressed markers and had the morphology
of ganglion cells. The combination of insulin and FGF2 stimulated the regeneration of ganglion cells in kainate- and
colchicine-treated retinas. We conclude that exogenous growth factors can be used to stimulate neural regeneration in the
retina. We propose that the type of neuron destroyed in the retina may allow or promote the regeneration of that neuronal
type. © 2002 Elsevier Science (USA)INTRODUCTION
The discovery of neural stem cells in the adult central
nervous system has implied that neural regeneration may
be possible in birds and mammals. Several recent in vivo
studies have demonstrated that under certain circum-
stances there is limited regeneration of neurons in the
cortex of mice (Magavi et al., 2000), vocal nuclei of song-
birds (Scharff et al., 2000), and retina of chickens (Fischer
and Reh, 2001). While the numbers of newly generated
neurons that are produced in response to damage are few,
these studies provide hope that regenerative mechanisms
might somehow be enhanced to increase the replacement of
lost neurons. We have recently found that the combination
of insulin and FGF2 injected into the vitreous chamber of
the eye activates a neurogenic program in mature Mu¨ller
glia of the retina (Fischer et al., 2002b). It is possible that
these growth factors might stimulate neural regeneration
when applied to damaged retinas. One purpose of this study
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All rights reserved.was to test whether insulin and FGF2 stimulate the regen-
eration of neurons in toxin-damaged retinas.
We have recently demonstrated that Mu¨ller glia in the
chick retina are a potential source of neural regeneration
(Fischer and Reh, 2001). In response to NMDA-induced
excitotoxic damage, numerous Mu¨ller glia dedifferentiate,
re-enter the cell-cycle, and express proteins found in em-
bryonic retinal progenitors. The majority of cells generated
by proliferating Mu¨ller glia remain as undifferentiated
progenitor-like cells, while some differentiate into Mu¨ller
glia and a few differentiate into amacrine or bipolar neu-
rons. We found no evidence that photoreceptors or ganglion
cells were regenerated following NMDA-induced excitotox-
icity. It is possible that the types of neurons produced by
Mu¨ller glia-derived progenitors are influenced by the types
of cells that are destroyed, since NMDA destroys primarily
amacrine and bipolar neurons, while photoreceptor and
ganglion cells survive (Tung et al., 1990; Fischer et al.,
1998). For example, while projection neurons in the cortex
of adult rodents are not normally produced, selective de-
struction of projection neurons induces the regeneration of
this cell type (Magavi et al., 2000). In addition, the destruc-
tion of dopaminergic amacrine cells stimulates the selec-1524. E-mail: tomreh@u.washington.edu.367
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tive regeneration of this cell type in the larval frog retina
(Reh and Tully, 1986). To test whether the projection
neurons of the retina could be regenerated, we selectively
destroyed ganglion cells by using colchicine or by inducing
more general damage that included the destruction of
ganglion cells by using kainic acid (KA). KA is a potent
neurotoxin in the chick retina, destroying primarily bipolar,
amacrine, and ganglion cells (Ingham and Morgan, 1983;
Dvorak and Morgan, 1983; Ehrlich et al., 1987). By compari-
son, when applied on the day of hatching, colchicine
selectively destroys about 90% of ganglion cells (Morgan,
1981; Fischer et al., 1999) and nearly all dopamine- and
glucagon-containing amacrine cells (Fischer et al., 1999).
Here, we present data demonstrating that ganglion cells
are regenerated in retinas where ganglion cells have been
destroyed. Numbers of newly generated ganglion cells were
not increased by insulin or FGF2 alone, but were increased
when these factors were co-applied. These newly generated




The use of animals in these experiments was in accordance with
the guidelines established by the National Institutes of Health and
the University of Washington. Newly hatched leghorn chickens
(Gallus gallus domesticus) were obtained from HandN Highline
International (Seattle, WA) and kept on a cycle of 16 h light, 8 h
dark (lights on at 6:00 a.m.). Chicks were housed in clear Nalgene
cages at about 25°C. Chicks received water and Purina chick starter
ad libitum.
Injections
Chicks were anesthetized and injected as described elsewhere
(Fischer et al., 1998, 1999; Fischer and Reh, 2000). To destroy
retinal cells, we injected 200 nmol (42.6 g) of KA or 0.5 nmol (0.2
g) of colchicine in 20 l of sterile saline into the left eye on the day
of hatching, postnatal day 0 (P0). Growth factors were injected
every second day for 10 days starting at P5. We injected insulin (2
g/dose) or FGF2 (100 ng/dose), or a combination of these factors,
in 20 l sterile saline added with 2 g BrdU and 0.1 mg/ml bovine
serum albumin as carrier. All drugs were obtained from Sigma, and
all growth factors were obtained from R&D Systems.
Fixation, Sectioning, Whole Mounts, and
Immunocytochemistry
Retinas were dissected, fixed, sectioned, and immunolabeled as
described elsewhere (Fischer et al., 1998, 1999; Fischer and Reh
2000). For whole-mounted retinas, we following procedures de-
scribed elsewhere (Fischer et al., 2002a).
Working dilutions and sources of antibodies used in this study
included: mouse anti-BrdU at 1:50 (Developmental Studies Hybrid-
oma Bank), rat anti-BrdU at 1:80 (Accurate Chemicals), mouse
anti-neurofilament at 1:2000 (RMO270; Zymed), rabbit anti-Brn3.0
at 1:1000 (Dr. E. Turner, University of California San Diego),
mouse anti-Hu at 1:200 (Monoclonal Antibody Facility, University
of Oregon), rabbit anti-calretinin at 1:1000 (Swant, Bellinzona,
Switzerland), rabbit anti-visinin at 1:5000 (Dr. R.S. Polans, Dow
Neurological Institute, Portland, OR), and rabbit anti-protein ki-
nase C at 1:1000 (Research Diagnostics Inc.). Secondary antibodies
included goat anti-rabbit Alexa568, goat anti-mouse Alexa568, and
goat anti-rat Alexa488 (Molecular Probes Inc., Eugene, OR) diluted
to 1:500 in PBS plus 0.3% Triton X-100.
Histology
Toluidine blue staining was done as described elsewhere (Fischer
et al., 1998, 1999).
Photography, Measurements, Cell Counts, and
Statistical Analysis
Photomicrographs were taken by using a Ziess Axioplan II
microscope equipped with epifluorescence, FITC, and rhodamine
filter combinations, and a Spot Slider-RT digital camera (Diagnos-
tic Inc.). The data and confocal images in Fig. 3 were obtained by
using a Ziess Pascal LSM. Images were optimized for color,
brightness, and contrast, and double-labeled images overlaid by
using Adobe Photoshop 5.5. Montage figures were made by over-
laying the clearly focused portions of images from two or more
fields of view. Cell counts were made on at least four whole
mounts from different animals, and means and standard errors
calculated on data sets from at least four individuals. Data from
treated and control eyes were compared statistically with the
appropriate Student’s t test (StatView for Macintosh).
RESULTS
NMDA-, colchicine-, and KA-induced damage have been
well characterized in central regions of the chick retina
(Ingham and Morgan, 1983; Dvorak and Morgan, 1983;
Ehrlich et al., 1987; Morgan, 1981; Fischer et al., 1998,
FIG. 1. Colchicine- and KA-mediated destruction of ganglion cells is not uniform across the retina. (a–d) Vertical sections of retina that
were stained with toluidine blue. Retinas were obtained 16 days after a single injection of saline (a), NMDA (b), colchicine (c), or KA (d) on
the day of hatching (P0). (e–l) Retinal whole mounts that were labeled for neurofilament-immunoreactivity. Retinas were obtained 16 days
after an injection of saline (e, i), NMDA (f, j), colchicine (g, k), or KA (h, l). Photographs were taken in dorsal–peripheral regions (e–h) or
central regions (i–l) of the retina. Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL,
ganglion cell layer. The calibration bar (50 m) in (d) applies to (a–d), and the bar in (l) applies to (e–l). (m) Histogram illustrating the number
of ganglion cells per mm2 that survive treatment with NMDA, colchicine, or kainate.
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1999). However, the extent of damage in peripheral regions
of the retina (45o eccentricity) has not been described.
Accordingly, we sought to characterize the loss of cells in
peripheral regions of the retina that results from intraocular
applications of NMDA, colchicine, or KA.
We observed the loss of retinal cells in vertical sections of
the retina that were stained with toluidine blue. Consistent
with previous reports, NMDA, colchicine, and KA induced
a loss of thickness of the inner retinal layers (Figs. 1a–1d)
(Morgan, 1981; Fischer et al., 1999). The loss of retinal
thickness was greatest for KA-treatment, compared with
that observed with either NMDA or colchicine treatment
(Figs. 1a–1d). These data suggest that KA destroyed more
cells than NMDA or colchicine.
To assay the loss of ganglion cells, we labeled retinal
whole mounts with antibodies to neurofilament. In saline-
treated eyes, we observed that the density of neurofilament-
positive axons in the NFL was not uniform across all
regions of the retina. For example, the density of axons in
the NFL was less in peripheral regions of the retina (Fig. 1e)
compared with that of more central regions of the retina
(Fig. 1i). While there was no obvious loss of neurofilament-
immunoreactive ganglion cells in retinas treated with
NMDA (Figs. 1f and 1j), retinas treated with colchicine or
KA suffered massive losses (Figs. 1g, 1h, 1k, and 1l).
Colchicine- and KA-induced losses of neurofilament-
expressing ganglion cells were not uniform across the
retina. In dorsal regions of retinas treated with colchicine or
KA, within several mm of the injection site, the loss of
neurofilament-immunoreactive ganglion cells was severe
(Figs. 1g and 1h). Many surviving ganglion cells were large,
with somata up to 15 m in diameter and dendritic arbors
spanning as much as 400 m, while other surviving gan-
glion cells were smaller, with somata about 7 m in
diameter and dendritic arbors about 150 m in diameter.
Many more ganglion cells survived in central and ventral
regions of the retina (Figs. 1k and 1l) compared with
dorsal/peripheral regions of the retina (Figs. 1g and 1h).
To determine the extent of ganglion cell loss following
treatment with different neurotoxins, we made cell
counts from whole-mount preparations. Consistent with
previous reports (Chen and Naito, 1999), we found about
10,000 ganglion cells per mm2 in central regions of
the retina, and about 4,000 ganglion cells per mm2 in
dorsal peripheral regions of the retina (Fig. 1m). NMDA
treatment did not significantly affect the number of
FIG. 2. Damage and exogenous growth factors stimulate proliferation within the retina. (a–h) Whole-mount preparations of the retina that
were labeled for BrdU-immunoreactivity. Retinas were obtained from eyes that were treated with saline (a, c, e, g) or colchicine (b, d, f, h)
on the day of hatching. Subsequently, eyes were injected with saline (a, b), FGF2 alone (c, d), insulin alone (e, f), or both insulin and FGF2
(g, h) at P3, P5, P7, P9, and P11. Retinas were processed for immunocytochemistry at P16. The calibration bar (50 m) in (h) applies to (a–h).
(i) Histogram illustrating the mean number of BrdU-labeled cells in dorsal regions of the retina (90,000 m2) with various toxin and growth
factor treatments.
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FIG. 3. Proliferating cells accumulate in different retinal layers depending on the type of damage and treatment with insulin and FGF2.
(a–d) Confocal images of whole-mounted retinas that were labeled with antibodies to BrdU. Optical sections were obtained from the GCL
and NFL, INL, or ONL. Retinas were obtained from eyes that were treated with NMDA or KA and saline or insulin and FGF2.
Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; NFL, nerve fiber layer; NMDA, N-methyl-D-
aspartate; KA, kainic acid. The calibration bar (100 m) in (d) applies to panels (a–d). (e) Histogram demonstrating the total number of
BrdU-labeled cells in the ONL, INL, or GCL of retinas treated with NMDA or KA and saline or insulin and FGF2. The significance (*, P 
0.005; **, P  0.01) of difference between the means of KA/insulin  FGF2 and NMDA/insulin  FGF2 was assessed by ANOVA followed
by a posthoc Student’s t test. (f) Histogram illustrating the relative percentages of BrdU-labeled cells in the GCL/NFL, INL, or ONL.
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FIG. 4. Damage to the retina results in the regeneration of neurofilament-expressing ganglion cells. (a) Histogram illustrating numbers of
BrdU/neurofilament-labeled cells in toxin-damaged retinas treated with saline, insulin alone, FGF2 alone, or insulin plus FGF2. Retinas
were damaged by a single intraocular injection of NMDA, colchicine, or KA on the day of hatching. (b–m) Retinal whole-mount
preparations were double-labeled for BrdU (in green) and neurofilament (in red). Retinas were obtained from eyes that were treated with KA
(b–j) or colchicine (k–m) on the day of hatching. The plane of focus of all images was in the ganglion cell layer. The cells in these images
were found between 1 and 4 mm into the retina, away from the retinal margin. The significance (*, P  0.005) of difference between the
means of insulin and insulin FGF2 was assessed by ANOVA followed by a posthoc Student’s t test. Arrows indicate cells labeled for BrdU
and neurofilament. The calibration bar (50 m) in (g) applies to (b–g); the bar in (j) applies to (h–j); and the bar in (m) applies to (k–m).
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ganglion cells in central and peripheral regions of the
retina (Fig. 1m). By contrast, colchicine and KA caused
massive losses of ganglion cells in both central and pe-
ripheral regions of the retina. In comparison, fewer gan-
glion cells survived exposure to KA compared with num-
bers of ganglion cells that survive exposure to colchicine
(Fig. 1m)
Toxin-Induced Cell Loss and Exogenous Growth
Factors Stimulate the Proliferation of Cells
in the Retina
We have shown previously that NMDA-induced retinal
damage causes Mu¨ller glia to go through only one round of
division, entering S-phase 2 days after the toxin was applied
(Fischer and Reh, 2001). To assay cell proliferation in
retinas treated with colchicine and KA, we injected the
thymidine analogue 5-bromo-2-deoxyuridine along with
growth factors into the vitreous chamber. Five injections
were made every other day starting at P5, and retinas were
processed for immunocytochemistry at P21, 5 days after the
final injection. In saline-treated eyes that received injec-
tions of BrdU in saline, we found a few BrdU-labeled cells
(Figs. 2a and 2i). Most of these cells were in the NFL and
GCL (data not shown). In toxin-damaged retinas that re-
ceived injections of BrdU in saline, we found significantly
more BrdU-labeled cells than in undamaged retinas (Figs. 2b
and 2i). Undamaged and toxin-treated retinas that received
injections of FGF2 alone did not contain increased numbers
of BrdU-labeled cells (Figs. 2c, 2d, and 2i). In undamaged
retinas that were injected with insulin alone, we found
increased numbers of BrdU-labeled cells compared with
numbers observed in undamaged, saline-treated eyes (Figs.
2e and 2i). The number of BrdU-labeled cells in retinas
treated with insulin alone was increased in toxin-damaged
eyes compared with numbers observed in undamaged,
insulin-treated eyes (Figs. 2f and 2i). The greatest numbers
of BrdU-labeled cells were observed in retinas treated with
both insulin and FGF2, regardless of toxin treatment (Figs.
2g–2i).
To determine whether toxin-induced damage or injec-
tions of growth factors influence where proliferating cells
accumulate within the retina, we used laser-scanning con-
focal microscopy to quantify the distribution of BrdU-
labeled cells within the cell layers of the retina. In retinas
damaged by NMDA or KA and treated with BrdU in saline,
the number of BrdU-labeled cells was not significantly
different between toxin treatments, with most of the cells
in the GCL/NFL, few in the INL, and none in the ONL
(Figs. 3a, 3b, 3e, and 3f). By contrast, in undamaged retinas
that received doses of insulin and FGF2, we found increased
numbers of BrdU-labeled cells; most of these cells were in
the INL and some were found in the ONL (Figs. 3c, 3e, and
3f). Numbers of BrdU-labeled cells in the GCL/NFL, INL, or
ONL were not significantly different in retinas damaged by
NMDA and treated with insulin and FGF2 compared with
numbers observed in undamaged retinas treated with insu-
lin and FGF2 (Figs. 3c, 3e, and 3f). In retinas damaged by KA
and treated with insulin and FGF2, increased numbers of
BrdU-labeled cells were in the GCL and decreased numbers
FIG. 5. The destruction of ganglion cells and treatment with insulin and FGF2 induces the regeneration of Brn3.0-expressing
ganglion cells. Whole-mount preparation of retinas that were treated with saline (a), colchicine (b–d), or KA (e–g) on the day of
hatching. Tissues were obtained from eyes that received five consecutive bidaily injections of insulin and FGF2 from P3 to P11.
Arrows indicate cells double-labeled for BrdU and Brn3.0. The calibration bar (50 m) in (a) applies to (a) alone, and the bar in (g) applies
to (b–g).
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in the ONL, compared with numbers of BrdU-labeled cells
observed in undamaged and NMDA-damaged retinas
treated with insulin and FGF2 (Figs. 3c–3f). This finding
suggests that the destruction of ganglion cells by KA and
subsequent application of insulin and FGF2 increases the
recruitment of BrdU-labeled cells to the GCL.
Toxin-Induced Cell Loss and Insulin Plus FGF2
Stimulate the Regeneration of Ganglion Cells
To assay for the production of ganglion cells, we used
retinal whole-mount preparations that were immunola-
beled for BrdU and neurofilament. We did not observe any
BrdU/neurofilament-labeled cells in NMDA-treated reti-
nas, where there was little or no loss of ganglion cells (Fig.
4a). In retinas treated with colchicine or KA, we found
BrdU/neurofilament-positive cells within the retina. These
cells were found primarily in peripheral regions of the
retina, within 4 mm from the retinal margin. Most of these
cells (78.5%) were found in dorsal regions of the retina,
where losses of ganglion cells were greatest. Regardless of
the type of toxin treatment, the abundance of newly gener-
ated neurofilament-immunoreactive cells within the retina
was not increased significantly by treatment with insulin
alone or FGF2 alone (Fig. 4a). By comparison, coinjection of
insulin and FGF2 significantly (P  0.005) increased the
number of BrdU/neurofilament-labeled cells in dorsal re-
gions of retinas damaged by colchicine or KA (Fig. 4a).
However, we never observed BrdU/neurofilament-labeled
cells in NMDA-treated retinas that were treated with the
combination of insulin and FGF2 (Fig. 4a). Regardless of
growth factor treatment, there were significantly (P 
0.005) more BrdU/neurofilament-labeled cells in retinas
treated with KA compared with the numbers of these cells
in retinas treated with NMDA or colchicine (Fig. 4a).
Cells labeled for BrdU and neurofilament had a variety of
morphologies. Some BrdU/neurofilament-labeled cells
formed few local processes lacking well-defined dendritic
arbors or axons (Figs. 4b–4d). These cells may have been in
early stages of differentiation. Other cells appeared to be in
an intermediate stage of differentiation with numerous
short dendrite-like processes (30 m in length; Figs.
4e–4g). Most BrdU/neurofilament-positive cells were rela-
tively small, with somata about 8 m in diameter, and
formed numerous peripheral processes (Figs. 4h–4j). A few
BrdU/neurofilament-positive cells were large, with somata
up to 14 m in diameter, and formed extensive peripheral
processes (Figs. 4k–4m).
In the chicken retina, neurofilament is express by gan-
glion cells and efferent target cells (Bennett and DiLullo,
1985a,b; Pittack et al., 1997; Fischer and Stell, 1999). To
further investigate the phenotype of BrdU/neurofilament-
labeled cells, we probed retinal whole mounts for BrdU- and
Brn3.0-immunoreactivity. Brn3.0 is a homeotic transcrip-
tion factor that contains a POU domain and is known to be
required for the differentiation and survival of retinal gan-
glion cells (Xiang et al., 1993; Gan et al., 1996; Liu et al.,
2001). In the postnatal chicken retina, Brn3.0 is expressed
by only orthotopic ganglion cells (Fischer et al., 2002a). In
whole-mount preparations of undamaged retina, we found
numerous Brn3.0-immunoreactive cells in the GCL (Fig.
5a). In eyes that were damaged by colchicine or KA and
received injections of insulin and FGF2, we found cells that
were labeled for BrdU and Brn3.0 (Figs. 5b–5g). This sug-
gests that many of the newly generated neurofilament-
labeled cells were ganglion cells. These cells were observed
up to 4 mm away from the retinal margin, toward central
regions of the retina.
To confirm findings in retinal whole mounts, we probed
for newly generated neurons in retinal sections. In both
normal and toxin-treated retinas, neurofilament-
immunoreactivity is weak in the somata of ganglion cells
and is difficult to clearly localize. Therefore, we probed for
newly generated neurons by using antibodies to Hu, an
RNA-binding protein related to ELAV proteins of Drosoph-
ila (Marusich et al., 1994; Barami et al., 1995). In the
postnatal chick retina, Hu is expressed by most, if not all,
amacrine and ganglion cells (Fischer and Reh, 2000, 2001).
In retinas damaged by colchicine or KA, we found Hu-
immunolabeled cells that were positive for BrdU, regardless
of growth factor injections. Most of these cells (57 of 84
cells counted) were found near the GCL (Figs. 6a–6c), while
a few of these cells were found in the INL (20/84; Figs.
6d–6f). Occasionally, we observed Hu/BrdU-labeled cells in
the ONL (7/84; Figs. 6g–6i), where this cell type normally is
not situated, suggesting that the distribution of newly
generated neurons in toxin-damaged retinas may be abnor-
mal. By comparison, we never observed neurofilament/
BrdU-positive cells in retinal layers other than the GCL.
Hu/BrdU-positive cells were found up to 4 mm from the
peripheral edge of the retina.
We found many BrdU-labeled cells in the ONL and distal
INL, where the cell bodies of photoreceptor, horizontal and
bipolar cells, respectively, are known to reside. However, we
did not find any BrdU-labeled cells that were colabeled with
the photoreceptor marker visinin, the horizontal cell marker
calretinin, or the bipolar cell marker protein kinase C.
DISCUSSION
Here, we report that neural regeneration in the chicken
retina can include the regeneration of ganglion cells. This
cell type was regenerated only in retinas where ganglion
cells were destroyed and in regions of retina with signifi-
cant losses of ganglion cells (Fig. 7). We also found that the
combination of insulin and FGF2 stimulated the regenera-
tion of ganglion cells, while these factors applied separately
had no effect on the number of regenerated neurons.
Some of the BrdU/neurofilament-positive cells in toxin-
treated retinas were likely to be newly generated ganglion
cells. In normal chicken retinas, neurofilament is expressed
selectively by ganglion cells (Torelli et al., 1989; Bradshaw
et al., 1995; Pittack et al., 1997) and efferent target cells
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(Fischer and Stell, 1999). However, neurofilament is ex-
pressed transiently by Mu¨ller glia in following toxin-
induced retinal damage (Fischer and Reh, 2001) or following
intraocular injections of exogenous insulin and FGF2 (Fi-
scher and Reh, unpublished observation). In both of these
cases, the expression of neurofilament lasted only a few
days and returned to normal by 4 days after treatment. In
the current study, we probed for the expression of neuro-
filament at least 5 days after the final dose of growth factor.
Therefore, levels of neurofilament expression should have
fallen below detectable levels in Mu¨ller glia by the time
we made our observations. Further, none of the BrdU/
neurofilament-positive cells had the morphology of Mu¨ller
glia; instead, these cells had neuronal morphology (see Fig.
4). Further, we detected BrdU in the nuclei of cells that
expressed the ganglion cell-specific markers Brn3.0 and Hu,
confirming that at least some of the newly generated cells
in retinas damaged by colchicine or KA are ganglion cells.
In addition to the neurofilament/BrdU-labeled cells, we
observed many cells labeled with BrdU alone in saline- and
insulin-treated retinas in the GCL or NFL. These cells may
have been oligodendrocytes. In the chick retina, although
astrocytes are confined to the optice nerve head (Schuck et
al., 2000), oligodendrocytes migrate into the retina from the
optic nerve (Huxlin et al., 1992; Ono et al., 1998) and reside
in the GCL and NFL (Villegas, 1960; Nakazawa et al., 1993;
Ono et al., 1998). Oligodendrocytes have been shown to
proliferate within the chick retina at about E14 (Nakazawa
et al., 1993). It is possible that insulin and FGF2 stimulated
the proliferation of oligodendrocytes in the postnatal chick
retina, and many of the BrdU-labeled cells that we observed
in the GCL and NFL were oligodendrocytes.
One potential source for the regenerated ganglion cells is
the Mu¨ller glia. We have recently reported that Mu¨ller glia
in the postnatal chicken retina are a source of neural
progenitors (Fischer and Reh, 2001). We demonstrated that
in response to sufficient damage elicited by NMDA, numer-
ous Mu¨ller glia re-enter the cell cycle, dedifferentiate,
express genes common to embryonic retinal progenitors,
and produce some amacrine and bipolar neurons and some
glia. In addition, we have recently reported that intraocular
injections of insulin and FGF2 stimulated the production of
new neurons from mature, postmitotic Mu¨ller glia in the
absence of retinal damage (Fischer et al., 2002b). The
combination of insulin and FGF2 was required to stimulate
the proliferation and transdifferentiation of Mu¨ller glia,
while insulin alone or FGF2 alone had no effect. Similarly,
in the present study, we found that the combination of
insulin and FGF2 increased the number of newly generated
ganglion cells, while insulin alone or FGF2 alone had no
effect. Taken together, these findings suggest that injec-
tions of insulin and FGF2-stimulated Mu¨ller glia to regen-
erate ganglion cells in toxin-damaged retinas.
An alternative source of the regenerated ganglion cells is
the progenitors at the retinal margin. The progeny of these
cells could have migrated laterally into the retina and,
subsequently, differentiated into ganglion cells. In this
study, we observed newly generated neurons up to 4 mm
away from the retinal margin (Fig. 6). Given that the first
application of BrdU was about 2 weeks prior to observation,
ample time elapsed for a migrating cell to travel 4 mm.
However, long-distance lateral migration of neuroblastic
cells within the retina has not been previously observed. A
final possibility is that regenerated ganglion cells were
derived from quiescent stem cells that are seed within the
retina. For example, a population of quiescent stem cells
has been described in the adult teleost retina (Julian et al.,
1998; Otteson et al., 2001). Quiescent neural stem cells
may also exist in the postnatal chicken retina, but there is
currently no evidence to support this hypothesis.
The mechanisms underlying the synergistic activity of
insulin and FGF2 remain uncertain. We report here that
insulin or FGF2 alone did not increase numbers of regener-
ated ganglion cells, while the combination of these two
factors had a significant effect. Insulin and FGF have been
shown to act in synergy in a variety of biological systems
(Chamberlain et al., 1991; Werther et al., 1993; Frodin and
Gammeltoft, 1994; Reape et al., 1996; Liu et al., 1996). We
have reported elsewhere that in undamaged retinas the
combination of insulin and FGF2 stimulates the production
of ganglion cells by progenitors at the retinal margin
(Fischer et al., 2002a) and activates a neurogenic program in
postmitotic Mu¨ller glia in the absence of retinal damage
(Fischer et al., 2002b). Receptors for FGF2 and insulin/IGF
are likely to be coexpressed by Mu¨ller glia. Receptors for
FGF2 and insulin/IGF are expressed throughout the chick
retina (Waldbillig et al., 1991; de la Rosa et al., 1994; Rohrer
et al., 1997; unpublished observations). Activation of recep-
tors for FGFs or insulin results in the activation of a MAP
kinase signaling cascade (Boulton et al., 1991; reviewed by
Szebenyi and Fallon, 1999). In the retina, activated MAP
kinase signaling is commonly observed in Mu¨ller glia (Peng
et al., 1998; Wahlin et al., 2000; Kinkl et al., 2001; Takeda
et al., 2002). It is possible that the cumulative activation of
the MAP kinase pathway by both insulin and FGF2 is
required to activate a neurogenic program in Mu¨ller glia in
the chick retina, and thus increase the number of regener-
ated ganglion cells in toxin-damaged retinas.
Our findings suggest that the loss of ganglion cells
somehow allows or promotes their regeneration. Alterna-
tively, the types of neurons that survive toxin treatment in
the chick retina may regulate the types of cells that are
regenerated. We have reported previously that bipolar and
amacrine neurons are regenerated in retina damaged by a
single toxic dose of NMDA (Fischer and Reh, 2001). In
NMDA-treated retinas, we did not observe the regeneration
of any cells in the GCL, including displaced cholinergic
amacrine cells (Fischer and Reh, 2001). NMDA destroys
primarily amacrine and bipolar cells, while leaving photo-
receptor and ganglion cells intact (Tung et al., 1990; Fischer
et al., 1998). By comparison, we observed regenerated gan-
glion cells in retinas that were damaged by colchicine or
KA. We found that these toxins destroyed numerous gan-
glion cells, consistent with the reports of others (Ingham
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and Morgan, 1983; Dvorak and Morgan, 1983; Morgan,
1981; Fischer et al., 1999). It is possible that the destruction
of ganglion cells allows some of the progeny of proliferating
Mu¨ller glia to differentiate as new ganglion cells. Consis-
tent with this hypothesis, we observed increased numbers
of regenerated neurons where more cell loss had occurred.
For example, more ganglion cells were regenerated in KA-
treated retinas compared with colchicine-treated retinas,
and KA caused greater ganglion cell loss than colchicine. In
addition, the regenerative response was greater in dorsal
retinal regions near the site of toxin injection. Consistent
with these findings, the selective destruction of dopaminer-
gic amacrine cells in the larval tadpole retina results in the
selective regeneration of this cell type at the retinal margin
(Reh and Tully, 1986), and KA-induced retinal cell loss
causes in an increase in the production of inner retinal
neurons from stem cells at the retinal margin (Reh, 1987).
Further, Magavi et al. (2000) reported that selective ablation
of projection neurons in the cortex of adult mice selectively
stimulated the regeneration of this cell type. It is possible
FIG. 6. Damage to the retina results in the regeneration of Hu-expressing retinal neurons. Vertical retinal sections were double-labeled
for BrdU (in green) and Hu (in red). Retinas were obtained from eyes that were treated with colchicine on the day of hatching, and received
doses of insulin plus FGF2 every second day for 10 days starting at P3. Retinas were processed for immunocytochemistry at P16.
Hu/BrdU-labeled cells were found in GCL (a–c), INL (d–f), or ONL (g–i). The calibration bar (50 m) in (f) applies to (d–f), and the bar in (i)
applies to (a–c) and (g–i). Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer.
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that destroying a particular cell type allows for the replace-
ment of that cell type. This process may occur via a
feedback mechanism (Hinds and Hinds, 1974; Reh, 1987).
For example, the production and/or survival of ganglion
cells may be regulated by a feedback mechanism during
embryonic development (Waid and McLoon, 1998;
Gonzalez-Hoyuela et al., 2000).
We conclude that the types of cells regenerated in the
retina are influenced by the types of cells that are destroyed.
We further conclude that the numbers of regenerated neu-
rons can be increased by exogenous growth factors. We
propose that exogenous growth factors may used to stimu-
late glial cells to generate neurons in the retina and other
regions of the central nervous system.
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